|
|
|
Volumn 15, Issue 4, 1997, Pages 207-214
|
|
Are monotherapy options reasonable for T3 prostate cancer?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYPROTERONE ACETATE;
DIETHYLSTILBESTROL;
FLUTAMIDE;
LEUPRORELIN;
MEDROXYPROGESTERONE ACETATE;
PLACEBO;
PROSTATE SPECIFIC ANTIGEN;
CANCER HORMONE THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CRYOSURGERY;
HUMAN;
MALE;
MULTIMODALITY CANCER THERAPY;
ORCHIECTOMY;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
REVIEW;
TREATMENT OUTCOME;
ADENOCARCINOMA;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROSTATIC NEOPLASMS;
|
|
EID: 0030667828
PISSN: 10810943
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (55)
|
